CIPLA - Cipla | Wealthrox

Cipla

CIPLA · Pharma > Pharmaceuticals & Drugs · Chairman: Y K Hamied · MD: Umang Vohra · Listing date: Oct. 27, 1994 · Employees: 25672 · Mumbai · http://www.cipla.com

Stock Price vs Company Growth

1.3%

0.8%

1.1%

2.8%

3.9%

1.7%

19.1%

10y

10.6%

all

10.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,502 1.3%

1,310

1,570

Company Overview

Sales

27,548 Cr

Growth: 7.4%

Profit after Tax

5,273 Cr

Growth: 5.7%

Large Cap

1,21,326 Cr

P/E: 23.0x

Industry P/E: 34.4x

Fundamentals

Sales (Cr)	₹ 27,548
Growth	7.4%
EBITDA	25.9%
P/S	4.4x
Dividend	0.8%
P/E	23.0x
Book Value	₹ 386
PEG Ratio	3.1x
ROE	17.7%
P/B	3.9x

Shareholding Pattern

Institutions

Sbi Mutual Fund

3.45 %

Government Pension Fund Global

2.36 %

Life Insurance Corporation Of India

2.27 %

Icici Prudential Mutual Fund

1.68 %

Hdfc Mutual Fund

1.19 %

Promoters

Yusuf Khwaja Hamied

20.36 %

Sophie Ahmed

5.71 %

Mustafa Khwaja Hamied

4.29 %

Samina Hamied

2.22 %

Kamil Hamied

1.36 %

Others

Nps Trust

1.51 %

Icici Prudential Life Insurance Company Limited

0.93 %

Increase Decrease No change

Company Profile Detailed

The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing, trading and other incidental operations in India and International markets.ProductsGenerics and branded genericsSpecialtyConsumer healthAwards:2013:Ernst & Young awarded Dr. Y K Hamied with the Lifetime Achievement Award of the year 2013Dr.

Belongs to (50 Indices) view more

Investors (288)

m.k.hami...

kaustubh...

first.st...

Followers (45)

anusha.r...

deepak

abdul.ha...